This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor



In the article "Reduction of Alcohol Drinking in Young Adults by Naltrexone: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Efficacy and Safety" by Stephanie S. O’ Malley, PhD, and colleagues published in the February 2015 issue (J Clin Psychiatry 2015;76[2]:e207-e213), in Figure 1, the numbers of participants who discontinued intervention have been corrected as follows. In the naltrexone condition, the total n = 9 (not interested, n = 6; family emergency, n = 1; medical contraindication, n = 1; adverse event/not interested, n = 1). In the placebo condition, the total n = 7 (not interested, n = 6; medical contraindication, n = 1).

Volume: 79

Quick Links: Addiction , Substance Use Disorders